OCT 27, 2017 06:02 PM PDT

Novel Enzyme can Make Precise Base Pair Edits

WRITTEN BY: Carmen Leitch

Researchers have made many advances in gene-editing technology in recent years. While precise edits were possible, they were extremely challenging. Scientists have changed that with a new technique. Their procedure allows one base pair of DNA nucleotides to be changed from A:T to G:C, which could make correcting small, point mutations much easier, and may eventually help cure disease. Point mutations cause many human diseases. The work has been reported in Nature and is summarized in the following video.

Feng Zhang helped create a powerful gene-editing process called CRISPR/Cas9; he is a molecular biologist at the Broad Institute of MIT and Harvard and an HHMI-Simons Faculty Scholar. He was not involved in this work but believes this development is a "really exciting addition to the genome engineering toolbox. It's a great example of how we can harness natural enzymes and processes to accelerate scientific research."

CRISPR/Cas9 is designed to find a particular region of DNA, specific to each experiment, and then cuts the genomic DNA there, on both strands. The cell has repair machinery to fix errors in DNA, and it comes in after the cut is made to fix it. But those cuts and repairs can be a little unpredictable. This new enzyme allows for a far more specific approach. 

"CRISPR is like scissors, and base editors are like pencils," explained David Liu. He is a chemical and molecular biologist at Harvard University and the Broad Institute, and the corresponding author of the report. 

Last year, Liu and his team created a tool that could edit single base pairs, but it could only change C:G to T:A. Now they have taken it a step further. To do so, they had to create an enzyme in the lab. 

Postdoctoral researcher Nicole Gaudelli started with an enzyme that already exists, TadA, and aimed to make it into the desired molecule. In transfer RNA, TadA can convert the nucleotide adenine into inosine, a molecule that cells read as another nucleotide, guanine. To get the enzyme to make that change in DNA, Guadelli constructed libraries of TadA mutants in bacteria, which were forced to convert adenine to inosine that was inside of antibiotic resistance genes. That would allow the bacteria that were carrying the right TadA mutants to survive while others died; the researchers were thus able to obtain bacteria that contained mutant TadA, which could convert adenine to inosine in DNA.

Bacteria with the mutant TadA were able to repair mutations in their DNA to survive antibiotic treatments. The new lab-created enzyme was tweaked a little and got an addition – the Cas9 nickase enzyme. Now, the base editor could find the right place to cut and snip once on the opposite DNA strand. The cell then moves to repair the break and fills it in with the other nucleotide pair. Thus, A:T changes to G:C

One potent enzyme the researchers developed, ABE7.10, can perform the A:T to G:C swap in both bacteria and human genomes. There seems to be very few if any side effects and the enzyme has about a 50 percent efficiency. 

G:C to A:T mutations are responsible for roughly half of the 32,000 point mutations that cause human diseases. This new enzyme could one day be a great tool for those patients. ABE7.10 was able to change a mutation, in patient-derived cells, that causes a disease called hemochromatosis. Another application showed that ABE7.10 could add a mutation and restore the function of a human hemoglobin gene. This preliminary work shows the many possibilities.

CRISPR-Cas9 is a customizable tool that lets scientists cut and insert small pieces of DNA at precise areas along a DNA strand. The tool is composed of two basic parts: the Cas9 protein, which acts like the wrench, and the specific RNA guides, CRISPRs, which act as the set of different socket heads. These guides direct the Cas9 protein to the correct gene, or area on the DNA strand, that controls a particular trait. This lets scientists study our genes in a specific, targeted way and in real-time. / Credit: Ernesto del Aguila III, NHGRI

"We are hard at work trying to translate base editing technology into human therapeutics," Liu said, but many hurdles remain. Safety, efficiency, and base editor delivery methods still need to be designed and tested before base editing can be used to tweak the human genome. "Having a machine that can make the change you want to make is only the start," Liu said. "You still need to do all this other work, but having the machine really helps."


Sources: AAAS/Eurekalert! via HHMI, Nature

About the Author
  • Experienced research scientist and technical expert with authorships on 28 peer-reviewed publications, traveler to over 60 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
DEC 11, 2018
Cancer
DEC 11, 2018
FDA approves two new drugs for cancers with specific genetic mutations
Last month the FDA approved two new drugs for cancer, both drugs target cancers with specific genetic mutations which made geneticists and oncologists optimistic on the future of cancer thera...
DEC 11, 2018
Immunology
DEC 11, 2018
Autoimmunity Caused By Genetic Mutation
Research reveals a genetic mutation causes a protein binding site to alter its structure resulting in the development of chronic inflammation and autoimmunity...
DEC 27, 2018
Cell & Molecular Biology
DEC 27, 2018
Expanding Our Understanding of the Molecular Impact of Alcohol
Many people will soon experience the intoxication that comes with imbibing alcohol. Researchers have learned more about the mechanism of that impact....
DEC 28, 2018
Genetics & Genomics
DEC 28, 2018
The Epigenetic Profile of Sperm is Altered by Cannabis
There has been considerable debate about the safety of marijuana, which has only increased since the drug has been legalized in some states....
DEC 30, 2018
Genetics & Genomics
DEC 30, 2018
An Improved Alzheimer's Model Adds Genetic Diversity
Researchers created a mouse model of Alzheimer's disease that has more in common with the human disease than current models....
JAN 03, 2019
Genetics & Genomics
JAN 03, 2019
Why the Tuberculosis Bacterium Sickens Some but not Others
Incredibly, around 20% of the global population is infected with the microbe that causes TB, but only about 10% show any signs of illness....
Loading Comments...